Nuclear Medicine and Biology

Article	Citations
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter	51
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation	37
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry	31
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging	28
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.	23
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism	21
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/	21
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-64	20
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-74	17
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics	17
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-188	17
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors	16
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy	16
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks	16
Editorial Board	15
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information	14
Impact of Different 177Lu Sources and Precursor Variations on the Quality of 177Lu-Labeled Theranostics	13
Protocol for Automated Production of Radiofluorinated Boramino Acids	13
Electroamalgamation-and Chromatography-Based Eu/Tb Separation Procedures as a Proof of Concept for Separating 155Tb from Alpha-Irradiated 153Eu	12
18F-labelling of T cells for in vivo evaluation of CAR T cell therapy	12
Development of an Automated [18F]FBPA Synthesis Using a Commercially Available Precursor	11
A fully automated synthesis of [18F]Fluro-L-meta-tyrosine (FMT) on AllInOne synthesizer	11
Optimization and Routine Production of Gallium-68-Radiolabeled Agents Using a Cyclotron Liquid Target System and Automated Radiosynthesis	11
Radiosynthesis and first in vitro evaluation of [11C]Onalespib for Hsp90 cancer imaging	11
Preclinical and Initial Clinical Evaluation of 68Ga/177Lu-Labeled Heterodimer Agents Targeting both Somatostatin Receptor and Integrin αVβ3	11

Enhancing Tumor Uptake Efficiency of Radioimmunoconjugates through DLS-Based Aggregation Detection and Removal	11
A new, optimised diphosphine chemical platform for kit-based, receptor-targeted 99mTc and 188Re radiopharmaceuticals	11
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N	10
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information	10
Evaluation of Antibody-Based TREM2 PET in Mice: Contrasting Image-Derived Blood Normalization with the Standard %ID Normalization Method	10
Medical Radionuclide Production Using Nuclear Fusion	10
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen	10
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes	10
Radiosynthesis of Primary Amides Through 11C-Carbonylation by [11C]Carbon Monoxide Using GE FX Synthesis Modules	10
Radiolabeling yield dependency of post-dry distillation decay of astatine-211	10
ATP Synthase is a Promising Target for Non-Invasive Imaging of Activated and Non-activated Adipose Tissues	10
Domestic Production of Therapeutic Isotopes Via Fusion	10
Mitochondria-targeted radiocomplexes for cancer theranostics	9
Rhenium and technetium complexes in extremely low oxidation states	9
89Zr-immuno-PET guided preclinical development of targeted therapies: demonstrating utility by evaluating fusion proteins in vivo	9
Non-invasive imaging of neutrophils in acute sepsis	9
Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide	9
Combining High-Throughput Radiochemical Experimentation Techniques with “Design of Experiments” (DoE) to Accelerate the Radiosynthesis Optimization of Novel Radiopharmaceuticals	9
[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor	9
Next generation copper complexes for efficient production of radiolabeled aromatics	8
The theranostic Goldilocks radionuclide copper-67 produced at a biomedical cyclotron	8
Editorial Board	8
Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE	8
Development of Electrolytic Labeling of 211At to Iodotyrosine Derivatives	8
An efficient, versatile procedure for the [18F]-radiofluorination of base-sensitive tracers with high radiochemical conversion	8
Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide	8
Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor	8
Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM3	8
177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours	8
18F-MGX-110S detects proinflammatory innate immune responses in human cells and Alzheimer’s disease mice with high sensitivity	7
Imaging Glucose Metabolism and Dopaminergic Dysfunction in Sheep (Ovis aries) Brain Using Positron Emission Tomography Imaging Reveals Abnormalities in OVT73 Huntington’s Disease Sheep	7
A novel bispecific antibody for the enhanced delivery of radiopharmaceuticals to brain tumours	7
Surface Marker Diversity on Circulating Tumor Cells in Advanced Prostate Cancer Patients	7
Evaluation of [18F]TzPheBF3 cell uptake and intracellular iEDDA reactivity through in vitro studies using Hoechst-TCO	7
Design and Preclinical Evaluation of 68Ga-Labeled Covalently Modified Nectin-4 Targeting Peptide as a Potential Tumor Radiotracer	7
The development of [18F]-LQ-1-41 as a PET tracer for imaging KRAS G12D tumors	7
Non-Canonical Amino Acids Substitutions Modulate Biodistribution and Tumor Accumulation of FAP-Targeted Cyclic-peptide Radiotracers	7
Validation of an HPLC method for assessing the chemical and radiochemical purity of [18F]Sodium Fluoride radiopharmaceutical	6
Fully automated and optimized [68Ga]Ga-NODAGA-Exendin-4 radiolabelling process on the TRASIS miniAllinOne	6
Expression of concern “cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production“	6
Development of an HCAR1 radiotracer	6
Girentuximab (TLX250) as a theranostic tool in triple-negative breast cancer treatment	6
Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II	6
Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt	5
Editorial Board	5
Title Page	5
Current developments in the production of actinium-225 from thorium-229	5
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response	5
Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study	5
[55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma	5

Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information	5
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH	5
New prospects for 89Zr-immuno-PET in brain applications – Alpha-synucleinopathies	5
GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP1	5
Abstract withdrawn.	5
Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study	4
Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne	4
Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer	4
Cancer stem cell targeted short peptide for PET imaging using Cu-64 in breast cancer cell xenografted model	4
Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results	4
Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging	4
Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 2	4
Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer	4
Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production	4
Targeted Alpha Therapy of Ovarian Cancer with ²¹²Pb-Labeled Anti-PTK7 Antibody: Efficient Production at Non-Clinical Scale and Preclinical Insights	4
Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging	4
Synthesis of Bifunctional Macrocyclic Chelator	4
Quality Control of Therapeutic Radiopharmaceuticals: Assessment of Quality Control and In Vivo Biodistribution of Radiolysed [177Lu]Lu-PSMA-I&T	3
Development of Targeted Theranostics through Clinical Applicability Validation based on Pancreatic Cancer Patient-derived Organoid Platform	3
The development of a new type 103Pd/103mRh generator like cold brew coffee	3
Optimal energy interval for the cyclotron production of 68Ga using solid targets	3
Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages	3
Comparative radiobiology of human leukemia cells and opportunistic fungal cells post treatment with 225Ac- and 177Lu-radiolabeled antibodies	3
Design of innovative FAP-target modules for simultaneous delivery of CAR-T cell-and radiotherapy	3
Automated Purification of 64Cu with the GE FastLab For GMP Production	3
Evaluation of chelating agents based on pyridine-azacrown compounds H4PATA, PATAM, and H4PATPA for 68Ga and 177Lu	3
development of novel fap inhibitors for cancer imaging and therapy: from rapid uptake to prolonged retention	3
Imaging resistance to anti-androgens in prostate cancer by multimodal 13C-pyruvate hyperpolarized magnetic resonance spectroscopy and 18F-pivalate positron emission tomography	3
A decade of ubiquicidin development for PET imaging of infection: A systematic review	3
Novel Radiofluorinated Analogues of GSK321 for PET Imaging of mIDH1 in Gliomas	3
Demonstrating targeted delivery of an antisense oligonucleotide (ASO) to pancreatic insulin secreting-cells in non-human primates using positron emission tomography	3
Radio-HPLC for 225Ac-Radiopharmaceuticals: Considerations on the Retrospective Reconstruction of the 225Ac-Specific Radio-Chromatogram by Three Different Methods	3
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties	3
Editorial Board	3
Large Chelators for Large Radiometals: Endeavors to Complex Radium-223 and Barium-131 to Advance Targeted Alpha Therapy and Theranostics of Cancer	3
43Sc and 44Sc radiolabelling of biomolecules and their use in PET imaging	3
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information	3
89Zr-radiolabeling of p-NCS-Bz-DFO-anti-HER2 affibody immunoconjugate and in vitro assessment of its potential in HER2+ breast cancer imaging	3
Recent advances in understanding and improving the stability of 211At-radiopharmaceuticals	3
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy	2
Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors	2
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer	2
Development of [18F]DASA-10 for enhanced imaging of pyruvate kinase M2	2
The development of [11C]M503-1619 as a PET tracer for imaging α-synucleinopathies in Parkinson’s disease (PD)	2
2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation	2
Filtration of Blood for Radiometabolite Analysis in Human Subjects	2
The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics	2
Editorial Board	2
Ultra-fast and efficient conversion of [11C]CO2 into [11C]hydantoins via the Bucherer-Bergs multicomponent reaction	2
Development of small molecule PET-tracers targeting PD-L1	2
Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery	2
Targetry of 152Tb PET radioisotope, member of theranostic isotopes of Terbium	2
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands	2
Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors	2
NMB innovators series. Professor Michael R. Kilbourn, PhD: An enduring legacy of mentorship, scientific curiosity and research excellence	2
Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET	2
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells	2
A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB	2
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist	2
Target occupancy studies of rho-associated protein kinase inhibitors in nonhuman primate with [11C]ROCK201 PET	2
Quality assessment of cyclotron-produced 67Cu	2
Scale up production and purification of high specific activity lead-203 (203Pb)	2
Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN	2
Preclinical evaluation of two new neutrophil elastase inhibitors synthesized by palladium-mediated [11C]cyanations	2
Development of Astatine-211 labeling reaction using aryliodonium ylide	2
The development of terbium-155 and terbium-161 towards radiotheragnostic clinical applications	2
CONTENTS	2
Corticolimbic activation patterns during aversive audiogenic stress assessed by cerebral perfusion using [99mTc]HMPAO SPECT/CT	2
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications	2
Enhanced tumor retention of the novel LAT1-targeting PET probe [18F]FAMT-OMe: A comparative study with [18F]FAMT in glioma mouse models	2
Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform	2
Corrigendum to “radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans” [nuclear medicine and biology, 144–145 (2025); 109,011]	2
Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry	2
225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates	2
Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors	2
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids	2
Evaluation of Direct and Pretargeting Approaches for CD38 PET Imaging in NSCLC Mouse Model with Isatuximab Fragment	2
Metabolic profiling of mAChR ligands: In silico simulation vs LC-HRMS analysis	1
Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors	1
In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4	1

Imaging with Nanobody-based bimodal PET/fluorescence tracers for improved clinical decision making	1
Design of novel FAPI Target Modules for simultaneous diagnostic imaging, endoradiotherapy, and UniCAR T-cell immunotherapy	1
Streamlined Synthesis of [18F]FSPG on the GE FASTlab™ 2 Platform for Preclinical and Clinical Applications	1
Investigational Studies on Imaging CSF-1 Receptors in the Brain	1
103Ru/103mRh Auger electron emitter generator: a proof of concept	1
Laminated holmium-166-containing electrospun bandages for use against skin cancer	1
Determination of sorption limit values of ion exchange resins used in the production of yttrium chloride Y-90	1
Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience	1
CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes	1
PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis	1
Radiosynthesis and evaluation of [18F]SNFT-1 for imaging early tau deposition	1
Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies	1
Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake	1
Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections	1
Synthesis, Dosimetry and Pharm/tox studies of MAO-B Analogue ([11C]COU) for Positron Emission Tomographic Studies	1
Dopamine conjugation facilitates optical/PET imaging of polycations in vivo	1
[89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors	1
Comparative evaluation of radiolabeled bombesin analogs [177Lu]Lu-AMBA and [177Lu]Lu-RM2 for targeting GRPR in glioblastoma model	1
Production of no-carrier-added holmium-166 by double neutron capture reaction at McMaster University research reactor	1
Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci	1
Development of noninvasive measurement for monoacylglycerol lipase activity in the brain using positron emission tomography	1
Imaging and targeting S1PR1 in HER2+ tumors	1
Evaluation of 177Lu-DOTA-obinutuzumab as a new radionuclide therapeutic agent for CD20-expressing non-Hodgkin lymphoma	1
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma	1
Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer	1
Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography	1
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives	1
Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography	1
Evaluation of the combinationally glycated albumin nanoplatform for targeting the tumor microenvironment with minimized reticuloendothelial system uptake using PET imaging	1
Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations	1
Implementation and optimisation of scandium-44 and manganese-52 production at King’s College London for preclinical research	1
Enhancing anti-interleukin-6 antibody immunoPET and radiotherapy with chemotherapy	1
cGMP synthesis of 4-[18F]fluoro-1-naphthol, a novel PET tracer for imaging activation of innate immunity	1
Real-time tracking of micro- and nanoplastics in mice after pulmonary exposure	1
Preliminary in vitro evaluation of synaptic density with [3H]UCB-J and the pan-tau ligand [3H]OXD-2314 in chronic traumatic encephalopathy.	1
A cassette-based process for the multidose production of [11C]Acetate on the AllinOne	1
D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffold	1
Characterization of a new Cu selective resin for the separation of Cu from Ni and Zn targets	1
Myocardial kinetics of [11C]β-hydroxybutyrate in healthy pigs: Comparison of positron emission tomography imaging vs. arteriovenous balance methods	1
Copper-mediated radiofluorination: A battle against protodeboronation	1
Development of Potential 18F-labelled Radiotracers for Imaging of Mutant Huntingtin Fibrils in Huntington’s Disease	1
Evaluation of 18F-Fluorosulfurylated Fluorescein Derivatives as Hybrid PET/Optical Imaging Agents	1
ImmunoPET for mesothelin positive tissues using bio-orthogonal in-vivo click chemistry	1
Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation	1
Improving the quality of Ga radionuclides to achieve high radiolabeling yields	1
Development of a stabilized GRPR antagonist for targeted cancer theranostics	1
Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl	1
Editorial Board	1
HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial	1
Screening of mitochondrial dysfunction imaging radiopharmaceutical by targeting NDUFS1 using GCN and LSTM network	1
Development of [68Ga]Ga-DOTA-4AH29, a radiolabeled single-domain antibody for PET imaging of FAP-α expression in cancer	1
Production of High Specific Activity [203Hg]HgCl2 and Investigation into Storage and Chemical Stability of Synthesised Solutions of [203Hg]HgCH3	0
A 68Ga-labeled linear peptide-based PET radiotracers for imaging PD-L1 status in tumors	0
Preclinical development of CD133 targeted immunoPET probes	0
Effects of uncharged linker-modification of PSMA-617-based inhibitors on targeting properties and the pharmacokinetic profile	0
Utilizing Targeted Alpha Therapy and Immunotherapy in PDAC Models	0
Modulation of blood pharmacokinetics of 68Ga-labelled nanobody analogues targeting the platelet-derived growth factor receptor beta	0
Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone	0
Development of novel MnO2-based nanoparticles for PET/MRI-guided Alpha Therapy	0
Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancr	0
Application of copper (I) selective ligands for PET imaging of reactive oxygen species through metabolic trapping	0
Design and evaluation of new 99mTc/188Re-labeled TSPO-binding ligands for cancer theragnostic	0
Development of Approaches for High-Throughput Experimentation in Radiochemistry	0
Synthesis of Tritium-labeled Lu-PSMA-617: Alternative Tool for Biological Evaluation of Radiometal-based Pharmaceuticals	0
Column-Based Separation of High-Purity 99mTcO4- from Low Specific Activity 99Mo for Radiopharmaceutical Applications	0
Towards decreased Protodeboronation in the Late-Stage Copper-Mediated Radiofluorination of the Positron Emission Tomography Tracer for Tropomyosin Receptor Kinase [18F]TRACK	0
Preclinical Insights into [¹⁶¹Tb]Tb-DPI-4452 : A CA IX-Specific Radiopharmaceutical for Targeted Radionuclide Therapy	0
Polyacrylamide gel electrophoresis based method for investigation of metabolic stability of [68Ga]Ga-BOT5035 in vitro and in vivo	0
Prostate Cancer Treatment Using a 177Lu-labeled Gastrin-Releasing Peptide Receptor Antagonist: Monotherapy versus Combination Therapy with Everolimus	0
Synthesis of [64Cu]Cu+ complex for redox imaging and evaluation of its reactivity with reactive oxygen species	0
From Bench to Bedside: Advancing Cancer Treatments with Astatine-211 in Europe	0
Optimisation of Manufacturing and Quality Control Processes of Radiopharmaceuticals After First-in-Human Studies	0
Towards sustainable radiochemistry: Copper radioisotopes production from ZnO target and Gallium radioisotopes recovery from production waste	0
A 177Lu-labeled anti-HER2 dual variable domain antibody	0
Efficient and mild copper-labelling of sensitive targeting vectors with novel triazamacrocyclic chelator	0
Development of a PET ligand [18F]CSF-23 for Imaging of CSF1R in the Brain	0
Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study	0
Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine	0
Jugular Vein Access Ports for Radiopharmaceuticals Administration in Preclinical Studies	0
Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-133	0
Development of UK Astatine‑211 Production Capability	0
Chromophore-conjugated NCS-activated NODAGA is a versatile tool for quantitative prediction of protein-chelator conjugation for 64Cu-immunoPET	0
Bioorthogonal Radiolabeling of GABAAR α1 Subunit-Specific Antibody Fragment for PET imaging	0
Covalent Modification of Black Phosphorus Nanosheets with 89-Zirconium	0
Tracking Intravenously Injected Micro- and Nanoplastics with PET	0
Development and evaluation of [18F]SEN177 for the detection of glutaminyl-peptide cyclotransferase (QPCT) in the brain	0
PET Imaging Studies Using [64Cu]-probe in Infective Endocarditis Models Using Various Bacteria	0
Targeted ROR1 protein degradation combined with PET imaging reveals the role of ROR1 in overcomes EGFR Resistance in NSCLC	0
Utilizing a 44mSc/44Sc Generator as a Method for 44Sc Distribution	0
Radiolabeling and preclinical evaluation of [18F]AZ14193052, a novel CNS penetrant and subtype-selective fluorinated PET radioligand for PARP1	0
11C-MePro PET/CT Imaging in Normal Volunteers: Initial Evaluation of PET-based Human Biodistribution	0
Development of [18F]Fluoroedaravone, a Novel Radiopharmaceutical for Imaging Oxidative Stress	0
Development of Solid Target Technologies for 225Ac Production with Proton Bombardment	0
Investigation of a GPC-3-addressing peptide as potential radioligand for PET imaging of HCC	0
Site-specific 89Zr-labeling of a VHH construct as a half-life extending building block for PET and TRNT applications	0